Načítá se...

Management of diabetes mellitus in the elderly with canagliflozin: A newer hypoglycemic drug on the horizon

Canagliflozin is the first available oral inhibitor of sodium/glucose cotransporter 2 (SGLT2) in the market. At the outset it sounds excellent for the use in the elderly diabetic population, because of its minimal tendency to cause hypoglycemia. However, the clinician needs to exercise caution as it...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Pharmacol Pharmacother
Hlavní autoři: Sehgal, Vishal, Bajwa, Sukhminder Jit Singh, Sehgal, Rinku, Consalvo, John A
Médium: Artigo
Jazyk:Inglês
Vydáno: Medknow Publications & Media Pvt Ltd 2014
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4231550/
https://ncbi.nlm.nih.gov/pubmed/25422561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-500X.142428
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!